Abstract:Per- and Polyfluoroalkyl Substances (PFAS) bioaccumulate in the human body, presenting potential health risks and cellular toxicity. Their transport mechanisms and interactions with tissues and the circulatory system require further investigation. This study investigates the interaction mechanisms of six PFAS with Human Serum Albumin (HSA) using multi-spectroscopy, DFT and a molecular dynamics approach. Multi-spectral analysis shows that perfluorononanoic acid (PFNA) has the best binding capabilities with HSA. The order of binding constants (298 K) is as follows: "Perfluorononanoic Acid (PFNA, 7.81 × 106 L·mol−1) > Perfluoro-2,5-dimethyl-3,6-dioxanonanoic Acid (HFPO-TA, 3.70 × 106 L·mol−1) > Perfluorooctanoic Acid (PFOA, 2.27 × 105 L·mol−1) > Perfluoro-3,6,9-trioxadecanoic Acid (PFO3DA, 1.59 × 105 L·mol−1) > Perfluoroheptanoic Acid (PFHpA, 4.53 × 103 L·mol−1) > Dodecafluorosuberic Acid (DFSA, 1.52 × 103 L·mol−1)". Thermodynamic analysis suggests that PFNA and PFO3DA's interactions with HSA are exothermic, driven primarily by hydrogen bonds or van der Waals interactions. PFHpA, DFSA, PFOA, and HFPO-TA's interactions with HSA, on the other hand, are endothermic processes primarily driven by hydrophobic interactions. Competitive probe results show that the main HSA–PFAS binding site is in the HSA structure's subdomain IIA. These findings are also consistent with the findings of molecular docking. Molecular dynamics simulation (MD) analysis further shows that the lowest binding energy (−38.83 kcal/mol) is fund in the HSA–PFNA complex, indicating that PFNA binds more readily with HSA. Energy decomposition analysis also indicates that van der Waals and electrostatic interactions are the main forces for the HSA–PFAS complexes. Correlation analysis reveals that DFT quantum chemical descriptors related to electrostatic distribution and characteristics like ESP and ALIE are more representative in characterizing HSA–PFAS binding. This study sheds light on the interactions between HSA and PFAS. It guides health risk assessments and control strategies against PFAS, serving as a critical starting point for further public health research.

What problem does this paper attempt to address?

The problem this paper attempts to address is understanding the binding affinity and mechanisms between six types of PFAS (Perfluorononanoic acid, Perfluoro-2,5-dimethyl-3,6-dioxanonanoic acid, Perfluorooctanoic acid, Perfluoro-3,6,9-trioxadecanoic acid, Perfluoroheptanoic acid, and Dodecafluorosuccinic acid) and human serum albumin (HSA). Specifically, the researchers systematically explored the binding characteristics, structural changes, and thermodynamic properties of these PFAS compounds with HSA using methods such as multi-spectral techniques, density functional theory (DFT) calculations, and molecular dynamics simulations. The study of these issues is of great significance for assessing the biological and environmental effects of PFAS, as well as guiding health risk assessment and control strategies. ### Main Research Questions: 1. **Binding Affinity**: Determine the binding constants of the six PFAS with HSA and compare their binding abilities. 2. **Binding Mechanism**: Investigate the main driving forces for the binding of PFAS with HSA, such as hydrogen bonds, van der Waals forces, or hydrophobic interactions. 3. **Structural Changes**: Analyze the conformational changes of HSA after binding with PFAS. 4. **Binding Sites**: Identify the main binding sites of PFAS on HSA. 5. **Thermodynamic Properties**: Study the thermodynamic behavior during the binding process of PFAS with HSA, including endothermic and exothermic processes. Through these studies, the authors hope to provide key scientific evidence for understanding the transport, distribution, and toxicity mechanisms of PFAS in the human body.

Binding Affinity and Mechanism of Six PFAS with Human Serum Albumin: Insights from Multi-Spectroscopy, DFT and Molecular Dynamics Approaches

Binding of Per- and Polyfluoroalkyl Substances (PFAS) to Serum Proteins: Implications for Toxicokinetics in Humans

In Vitro and In Silico Analysis of the Bindings between Legacy and Novel Per- and Polyfluoroalkyl Substances and Human Serum Albumin

Species-Specific Unbound Fraction Differences in Highly Bound PFAS: A Comparative Study across Human, Rat, and Mouse Plasma and Albumin

Perfluoroalkane sulfonyl fluorides non-covalently bind to human serum albumin at Sudlow's sites

The occurrence of PFAS in human placenta and their binding abilities to human serum albumin and organic anion transporter 4

An in vitro and machine learning framework for quantifying serum albumin binding of per- and polyfluoroalkyl substances

Insight into the binding model of per- and polyfluoroalkyl substances to proteins and membranes

Quantitative Cross-Species comparison of serum albumin binding of per- and polyfluoroalkyl substances from five structural classes

Investigation of the Interaction between Human Serum Albumin and Branched Short-Chain Perfluoroalkyl Compounds

Perfluoroalkyl Acid Binding with Peroxisome Proliferator-Activated Receptors α, γ, and δ, and Fatty Acid Binding Proteins by Equilibrium Dialysis with a Comparison of Methods

Structural Evidence of Perfluorooctane Sulfonate Transport by Human Serum Albumin

Unbound Fractions of PFAS in Human and Rodent Tissues: Rat Liver a Suitable Proxy for Evaluating Emerging PFAS?

In vitro binding analysis of legacy-linear and new generation-cyclic perfluoro-alkyl substances on sex hormone binding globulin and albumin, suggests low impact on serum hormone kinetics of testosterone

Underlying Mechanisms for the Impacts of Molecular Structures and Water Chemistry on the Enrichment of Poly/perfluoroalkyl Substances in Aqueous Aerosol

Critical new insights into the interactions of hexafluoropropylene oxide-dimer acid (GenX or HFPO-DA) with albumin at molecular and cellular levels

Species Difference? Bovine, Trout, and Human Plasma Protein Binding of Per- and Polyfluoroalkyl Substances

Elucidating the Molecular Mechanisms of Perfluorooctanoic Acid-Serum Protein Interactions by Structural Mass Spectrometry

PFAS Exposure Pathways for Humans and Wildlife: A Synthesis of Current Knowledge and Key Gaps in Understanding

Polyfluoroalkyl Substances Binding Properties and Impact on Human Health: Physiochemical Properties, Impact of Multiple PFAS Compounds, Variation among Species, and Fluoride Interaction

In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body